Cardiff Oncology, Inc. (CRDF)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.86
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.51
P/B Ratio
1.68
Institutional Ownership
35.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3.98M | $6.0M | 5.82% | -62.2K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.86M | $4.0M | 4.18% | -- | 2026-03-31 |
| Laurion Capital Management LP | 2.65M | $4.0M | 3.87% | -- | 2026-03-31 |
| Pfizer Inc | 2.41M | $3.0M | 3.53% | -- | 2026-03-31 |
| ACORN CAPITAL ADVISORS, LLC | 1.76M | $2.0M | 2.58% | -200.0K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.60M | $2.0M | 2.34% | +76.6K | 2026-03-31 |
| FRANKLIN RESOURCES INC | 1.21M | $1.0M | 1.76% | -- | 2026-03-31 |
| STATE STREET CORP | 1.19M | $1.0M | 1.74% | -4.7K | 2026-03-31 |
| BLAIR WILLIAM & CO/IL | 922.4K | $1.0M | 1.35% | -1.03M | 2026-03-31 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 595.1K | -- | 0.87% | -201 | 2026-03-31 |